By Mapaballo Borotho
- Patients using Enalapril 10mg Arya for high blood pressure are being urged to check their medication after four batches were recalled by Arya Pharma.
- The recall follows post-marketing inspections that identified out-of-specification results, prompting Sahpra to alert patients and healthcare facilities.
- Patients who have any of the affected batches are advised to contact their pharmacist or healthcare professional before switching to an alternative medication.
Hypertension patients who are using four certain batches of Enalapril 10mg Arya are urged to check if their medication is affected, following a recall from Arya Pharma.
The pharmaceutical company recalled four batches of its high blood pressure medication following post-marketing inspections that flagged out-of-specification results.
This recall has prompted the South African Health Products Regulatory Authority (Sahpra) to call on patients and healthcare facilities to immediately check whether they have any of the affected batches in their stock.
The affected batches include:
| Product | Batch/Lot | Pack Size | Manufacturing Date | Expiry Date |
|---|---|---|---|---|
| Enalapril 10 mg Arya | GQQ24053 | 28s | September 2024 | August 2026 |
| Enalapril 10 mg Arya | GQQ24064 | 28s | October 2024 | September 2026 |
| Enalapril 10 mg Arya | GQQ24066 | 28s | October 2024 | September 2026 |
| Enalapril 10 mg Arya | GQQ24067 | 28s | October 2024 | September 2026 |
Patients who have one of the affected batches have been advised to contact their pharmacist or healthcare professional for advice and, where necessary, to request an alternative medicine.
READ NEXT:
